Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-11

Clinical Trial Update: An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006) [Phase 1]

View source ↗

Summary

A Phase 1 trial of the investigational drug MK-0941-006 in adults with Type 2 Diabetes Mellitus on basal insulin has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MK-0941-006

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2012-07-11